GW328267X
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GW328267X, covering 2017-06-12 to 2017-06-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers [Phase 1]